agilon health to effect 1-for-25 reverse stock split on March 30, 2026 to maintain NYSE listing

agilon health, inc.

Stockholders approved reverse split at special meeting on March 17; votes were 356,574,789 for, 6,187,388 against, 365,864 abstained.
Board set ratio at 1-for-25; effective 5:01 p.m. ET March 30; split-adjusted trading begins March 31 under ticker AGL.
Approximately 16,605,993 shares outstanding post-split; no fractional shares issued, cash in lieu paid.
Reverse split intended to bring bid price above $1.00 to comply with NYSE continued listing requirements.
CUSIP for new shares: 00857U 206; transfer agent Computershare will handle exchange.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.